Biotech news
Refine search
Americas
Martin Blaser and Helen Hobbs were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Blaser and Hobbs were featured in the business and innovation section, as LSIPR reports. 5 October 2016
Americas
Jürgen Dressel and Judy Jarecki-Black were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Dressel and Judy Jarecki-Black were featured in the legal section, as LSIPR reports. 5 October 2016
Americas
Steve Bossone and Stephen Breyer were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Bossone and Breyer were featured in the legal section, as LSIPR reports. 5 October 2016
Africa
Jorge Kalil and Narendra Modi were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Kalil and Modi were featured in the government and policy section, as LSIPR reports. 5 October 2016
Americas
Francis Collins and James Greenwood were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Collins and Greenwood featured in the government and policy section, as LSIPR reports. 5 October 2016
Americas
Jarbas Barbosa da Silva Jr and Margaret Chan were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Love featured in the government and policy section, as LSIPR reports. 5 October 2016
Biotech
James Love was selected in the LSIPR 50 2016 publication for his influence on the life sciences industry. Love featured in the government and policy section, as LSIPR reports. 5 October 2016
Asia
Xi Jinping and George Freeman were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Jinping and Freeman were featured in the government and policy section, as LSIPR reports. 5 October 2016
Americas
Allergan and MedImmune have entered into a $1.52 billion licensing agreement under which Allergan has gained the global rights to develop MEDI2070, which treats inflammatory disorders. 4 October 2016
Americas
The $3.6 billion acquisition of the Thomson Reuters Intellectual Property & Science business by Onex Corporation and Baring Equity Asia was completed yesterday. 4 October 2016